Vivodyne
Vivodyne combines lab-grown human tissues, robotic laboratories, and AI to generate biological data for drug discovery and preclinical research. 5. Industry
- Artificial Intelligence
- San Francisco, California, United States
Company Overview
Vivodyne is a biotechnology company developing AI-powered drug discovery technologies using lab-grown human tissues, robotic experimentation, and machine learning. Founded by University of Pennsylvania bioengineers Andrei Georgescu and Dan Huh, the company aims to improve the ability of researchers to predict how potential medicines will behave in humans before clinical trials.In May 2025, Vivodyne announced $40 million in Series A financing led by Khosla Ventures. In August 2026, it announced a human biological datacenter containing 12 robotic HIVE laboratories, designed to generate large-scale human tissue data for training AI models of human biology. The company works with pharmaceutical partners to develop more predictive approaches to preclinical research and reduce reliance on traditional animal models.
QueryFeedz Insight
Vivodyne operates at the intersection of biotechnology, AI-driven drug discovery, and automated biological experimentation. Its platform addresses a key challenge in pharmaceutical research: generating large volumes of biologically relevant human data that can help researchers assess therapeutic candidates before clinical trials. By combining engineered human tissues with robotic laboratories and machine learning, Vivodyne aims to make preclinical experimentation more scalable and improve predictions of how drugs may affect people.
Funding & Investors
- Latest funding
- $40
- Latest round
- Series A
- Latest funding date
- May 2025
Investors
- Khosla Ventures — Led the 2023 seed financing and the 2025 Series A
- Kairos Ventures
- CS Ventures
- MBX Capital
- Bison Ventures
- Lingotto
- Helena Capital
- Fortius Ventures
Founders
- Andrei Georgescu — Co-Founder and CEO. Dan Huh — Co-Founder and Chief Scientific Officer (CSO)
Company Links
Reflect Orbital Visit Reflect Orbital website (opens in a new tab)
Artificial Intelligence
Reflect Orbital is developing space-based mirrors that redirect sunlight to Earth for potential applications in solar energy, emergency response, and remote-site lighting
Glean Visit Glean website (opens in a new tab)
Artificial Intelligence
Glean is an enterprise AI platform that connects company knowledge across applications, delivers context-aware answers, and helps organizations automate workflows with AI agents.
NewLimit Visit NewLimit website (opens in a new tab)
Artificial Intelligence
NewLimit is a biotechnology startup combining AI, genomics, and epigenetic reprogramming to develop medicines targeting age-related diseases and extending healthy human lifespan
Statsig Visit Statsig website (opens in a new tab)
Artificial Intelligence
Statsig provides product analytics, experimentation, feature flags, and session replay to help teams build and improve digital products using data. 5. Industry